Tweets
We've got a new podcast available for download! Dr Jack Cush reviews the news and journal reports and takes cases and questions from rheumatologists.
https://t.co/ErJJ5XL8NA
#RheumTwitter #RheumNow #medtwitter https://t.co/tqyVNyNYa4
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 10 months ago
ICYMI:
Population study shows risk of H. Zoster in adults to be high among bDMARD and CTX, also increased w/ AZA and HCQ but not MTX SSZ or LEF users. Data from 254065, 1,826311 Pt-Yrs F/U, 6295 new DMARD users, 17024 incident HZ https://t.co/1TeOAWN9LB
#RheumNow
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 10 months ago
ICYMI:
Probenecid, an OAT3 inhibitor, has inhibitory effects on RNA viruses (influenza, RSV) & decreases ACE2 expression. May have utility in COVID-19 as it was shown to inhibit SARS-CoV-2 replication in animal models https://t.co/MClSjpqpSa
#RheumNow
Dr. John Cush @RheumNow ( View Tweet )
4 years 10 months ago
Do More DMARDs Mean More Switching?
Tune in to this week's podcast to find out.
https://t.co/ErJJ5XL8NA
#RheumNow #RheumTwitter #medtwitter https://t.co/5Ufk0XQbmb
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 10 months ago
Looking for Rx updates? We’ve got them for you.
https://t.co/FOfqUvZ8nx
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 10 months ago
ACR Responds to 2022 Medicare Physician Fee Schedule Proposed Rule
Read more: https://t.co/SVGhfhp6Fg
#RheumNow #RheumTwitter #medtwitter https://t.co/g46wYCdary
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 10 months ago
Breakthrough COVID infection.
Breakthrough brilliance in a KOL
A must read from Len Calabrese
https://t.co/2Ljzau5nBG
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 10 months ago
A retrospective records review of patients with periodic fever syndromes (PFS) receiving IL-1 inhibitor treatment with canakinumab (CAN), shows CAN to be effective and safe in a variety of PFS patients. https://t.co/4lqMhE6ikx #RheumNow #RheumTwitter #medtwitter https://t.co/yThiwJhcwO
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 10 months ago
32 RA pts; each w/ 2 stool samples >6 mos apart - stool metagenome sequencing stool samples and pt activity assessed. Microbiome most influenced by age, followed by those achieving minimum clinically important improvement https://t.co/unaEOOuP34
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 10 months ago
Gitelman syndrome (GS) is common salt-wasting genetic tubulopathy causing hypokalaemia and hypomagnesemia. Chondrocalcinosis (CC) is a frequent feature of GS. Study of 57 GS pts - 79% had CC, esp in Cx spine, Knee & wrist. https://t.co/ctEAQq1zzL
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 10 months ago
Another non stellar result for remdesivir
Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): P3, randomised, controlled, open-label trial @TheLancetInfDis https://t.co/kNSNj9RM4K
Links:
Dr Philip Robinson @philipcrobinson ( View Tweet )
4 years 10 months ago
#ACR21 abstracts now online! NOTE: To coincide with virtual meeting early access, information that goes beyond that contained in the abstract is under embargo until Nov. 1 at 10 AM ET. Browse → https://t.co/o0fpZCHZLC https://t.co/SaNrNQPgau
Links:
American College of Rheumatology @ACRheum ( View Tweet )
4 years 10 months ago
